COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
aap Implantate AG successfully completes 10% capital increase at EUR 1.10, raising EUR 986,311.70 for human clinical trial of antibacterial implant technology -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
aap Implantate AG postpones the publication of the consolidated financial statements 2023 due to staff shortages. The Annual General Meeting may also be affected by this delay -
-
-
COMMUNIQUÉ DE PRESSE
aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
aap Implantate AG receives 100% approval to amend terms of mandatory convertible bond 2023/2028. Bondholders granted early conversion option without lock-up period. Strong support from creditors
